No Link Between Statin Use and Heart Attack Rates in Sweden
Author Information
Author(s): Staffan Nilsson, Sigvard Mölstad, Catarina Karlberg, Jan-Erik Karlsson, Lars-Göran Persson
Primary Institution: Linköping University
Hypothesis
Is there a correlation between statin utilization and the incidence or mortality of acute myocardial infarction in Sweden's municipalities?
Conclusion
The study found no correlation between the increasing use of statins and the incidence or mortality of acute myocardial infarction.
Supporting Evidence
- Statin utilization increased almost three times from 1998 to 2002.
- AMI incidence decreased for men but only slightly for women during the same period.
- Statin use showed no correlation with AMI mortality when adjusted for other factors.
Takeaway
Even though more people are taking statins, it doesn't seem to help reduce heart attacks in Sweden.
Methodology
The study analyzed data from 289 Swedish municipalities over a five-year period, examining statin utilization and AMI incidence and mortality.
Potential Biases
Potential ecological fallacy due to interpreting population-level data at the individual level.
Limitations
The study could not determine how much of the statins dispensed were actually consumed, and changes in diagnostic criteria for AMI limited comparisons.
Participant Demographics
Swedish population aged 40-79 years, with data collected from both men and women.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website